Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.

Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. (Chinese: 上海尹诺医药科技有限公司), which presents itself under the brand name Innogen Pharm (银诺医药), is a pharmaceutical technology company based in Shanghai, China. The company is recorded in public knowledge bases as a company in Shanghai, China, and it maintains an official corporate website at innogenpharm.com. Its Chinese-language web presence uses the name 银诺医药, indicating that the Innogen Pharm identity is the customer-facing brand for the Shanghai legal entity. The company operates in the pharmaceutical and biotechnology sector, where Chinese pharmaceutical technology firms typically engage in the research, development, and commercialization of drug products and related technologies. As a Shanghai-based entity, it sits within one of China's most concentrated life-science clusters, alongside a large ecosystem of contract research organizations, innovative drug developers, and pharmaceutical manufacturers. Because the available evidence is limited to the company's official website and basic registry-style descriptions, the precise product portfolio, pipeline, ownership structure, founding date, and leadership of Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. are not documented in the supplied sources. The dossier therefore records the verified identity, location, sector, and web presence of the company while marking the entry for further review where specific corporate details remain unconfirmed. For brand-knowledge purposes, the entity should be treated as a corporate brand in the Chinese pharmaceutical technology space, with the Innogen Pharm name serving as its primary commercial identity and 银诺医药 as its Chinese-language brand name.

Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. (上海尹诺医药科技有限公司) is a pharmaceutical technology company located in Shanghai, China. Public knowledge-base records describe it simply as a company in Shanghai, China, and its official web presence is maintained at innogenpharm.com under the Chinese brand name 银诺医药 (Innogen Pharm). The available evidence does not document the company's founding date, founders, ownership history, financing rounds, product approvals, or corporate milestones. Consequently, a detailed chronological history cannot be reconstructed from the supplied sources without speculation. What can be stated with confidence is that the company is an active Shanghai-based pharmaceutical technology enterprise with a bilingual brand identity: the English-language Innogen Pharm name and the Chinese-language 银诺医药 name. Shanghai hosts a dense pharmaceutical and biotechnology ecosystem, including multinational R&D centers, domestic innovative drug developers, and contract research and manufacturing organizations. Companies in this environment typically pursue activities such as drug discovery, preclinical and clinical development, regulatory affairs, and technology transfer or licensing. Whether Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. focuses on any specific therapeutic area, modality, or service line is not established by the evidence provided. As additional verified information becomes available — such as founding details, pipeline assets, partnerships, or regulatory filings — this history should be expanded. Until then, the entry should be treated as an identity-level record of a Chinese pharmaceutical technology corporate brand.

1. 1银诺医药官方网站innogenpharm.com
2. 2Wikidata: Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. (China)wikidata.org